An interventional study of stroke educational campaign: FAST and stroke educational campaign: STROKE 112 in Stroke, Cardiovascular, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-07.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Health services research
FAST and Stroke-112 are two campaigns to reduce the emergency room arrival time of stroke patients. No study has evaluated the effectiveness of these campaigns. This study aimed to compare recalling capacity of people in these two campaigns.
Cerebral vascular accidents have been one of the leading causes of death in Taiwan in recent years. In the modern medical system, treatment for hyperacute stroke including intravenous thrombolysis and intra-arterial thrombectomy. The faster patient received treatment, the better outcome he has.
Prehospital delay of acute stroke treatment has been an important issue in modern medical system. Awareness of stroke symptoms and calling for medical help immediately is the most important part of stroke health education. The most used educational campaign is FAST.
In recent years, there is another stroke educational campaign called STROKE 112. Previous study had showed it has greater acceptance, since the number is easier to remember then letter, especially in non-English speaking countries.
The investigators had conducted a hospital-based randomized study in 2019, which revealed that STROKE 112 had similar, but not superior effectiveness with FAST. However, more study is needed for community-based population.
This study will compare and explore the effectiveness of two stroke educational campaigns, FAST and STROKE 112, on community-based population by using the questionnaire, in Yunlin, Taiwan. The result will been compared and analyzed with previous study, help us modify and enhance our current stroke educational program, shorten the prehospital delay, and improve outcomes of patients with acute stroke.
The subjects will be randomized into either group: FAST or STROKE 112. Then the investigator will give a 15min eduacation. The evaluation will be arranged 5 days and 30 days after the first education, and the outcome is the recalling capacity of the stroke symptoms in the educational campaign.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's planned enrollment of 300 is above the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
stroke education: FAST
Other: stroke educational campaign: FAST
stroke education: STROKE 112
Other: stroke educational campaign: STROKE 112
After randomization, study staff provided 15-minute education on the selected campaign to each individual participant using educational pictures.
After randomization, study staff provided 15-minute education on the selected campaign to each individual participant using educational pictures.
The recalling capacity of the stroke symptoms mentioned in each campaign
Compare recalling capacity of people in these two campaigns: uneven face, weak arm, slurred speech. If the patient could recall one symptom, then he get 1 score. Total score is 3(which means the subject can recall all three symptoms)
Time frame: 5 days
The recalling capacity of the stroke symptoms mentioned in each campaign
Compare recalling capacity of people in these two campaigns: uneven face, weak arm, slurred speech. If the patient could recall one symptom, then he get 1 score. Total score is 3(which means the subject can recall all three symptoms)
Time frame: 30 days
Plan to share: No — No plan to share IPD
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital